Teladoc (TDOC) Shares Down 7% Following Q4 Results and Mixed Outlook

9
3
Favorite

Teladoc (TDOC) Shares Down 7% Following Q4 Results and Mixed Outlook

StreetInsider2022-02-23

Teladoc (NYSE: TDOC) shares were trading around 7% lower after-hours despite the company's reported Q4 results, with EPS of ($0.07) coming in better than the Street estimate of ($0.56). Revenue grew ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（3）

Chong135
·2022-02-23
The outlook shows that even the senior management thinks they not gonna grow by a large margin because :1. Omnicron not as deadly so people's mentality not as afraid and hence don't really need to visit doctor for help2. People's behaviour has not really switched to tele health services muchTherefore, we might need to see some sort of behavioural change in people for them to spark the growth they hope for.
Reply
1
Report
yaozong7
·2022-02-23
Poor teladoc. Low can go lower indeed
Reply
1
Report
Lavender00
·2022-02-23
Q4 EPS -0.07. Thought this is going to be profitable soon. next Q EPS highest estimated -0.50. [Speechless]
Reply
1
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2213957778?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-02-23 06:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2213957778","market":"us","top_or_hot":-1,"title":"Teladoc (TDOC) Shares Down 7% Following Q4 Results and Mixed Outlook","media":"StreetInsider","content":"<div>\n<p>Teladoc (NYSE: TDOC) shares were trading around 7% lower after-hours despite the company's reported Q4 results, with EPS of ($0.07) coming in better than the Street estimate of ($0.56). Revenue grew ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19658522\">Source Link</a>\n\n</div>\n","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Teladoc (TDOC) Shares Down 7% Following Q4 Results and Mixed Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTeladoc (TDOC) Shares Down 7% Following Q4 Results and Mixed Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-23 06:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19658522><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Teladoc (NYSE: TDOC) shares were trading around 7% lower after-hours despite the company's reported Q4 results, with EPS of ($0.07) coming in better than the Street estimate of ($0.56). Revenue grew ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19658522\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4167","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=19658522","article_id":"2213957778","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2213957778","pubTimestamp":1645569420,"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"Teladoc (NYSE: TDOC) shares were trading around 7% lower after-hours despite the company's reported ","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4167":"医疗保健技术","BK4534":"瑞士信贷持仓","BK4567":"ESG概念","BK4504":"桥水持仓","BK4548":"巴美列捷福持仓"},"translate_title":"Teladoc股价在第四季度业绩和前景喜忧参半后下跌7%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{},"content_text":"Teladoc (NYSE: TDOC) shares were trading around 7% lower after-hours despite the company's reported Q4 results, with EPS of ($0.07) coming in better than the Street estimate of ($0.56). Revenue grew 45% year-over-year to $554.2 million, compared to the Street estimate of $546.6 million. Access fees and visit fee revenues grew 51% and 21% to $469.9 million and $68.9 million, respectively.The company provided its outlook for Q1/22 and full 2022-year, which was mixed and are possibly the reason for shares sell-off after-hours.The company expects Q1/22 EPS in the range of ($0.60)-($0.50), compared to the consensus estimate of ($0.51), and revenue in the range of $565-571 billion, compared to the consensus estimate of $588.94 billion. For the full 2022-year, the company estimates revenue in the range of $2.55-2.65 billion, compared to the consensus estimate of $2.57 billion.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9030062252,"gmtCreate":1645581463065,"gmtModify":1676534042499,"author":{"id":"3578357426454921","authorId":"3578357426454921","name":"Chong135","avatar":"https://static.tigerbbs.com/1c56125729fc95aa1f1d4e0cfc2edea1","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3578357426454921","idStr":"3578357426454921"},"htmlText":"The outlook&nbsp;shows&nbsp;that even the senior management thinks they not gonna grow by a large margin because :1. Omnicron not as deadly so people's mentality not as afraid and hence don't really need to visit doctor for help2. People's behaviour&nbsp;has not&nbsp;really switched to tele health services muchTherefore, we might need to see some sort of behavioural change in people for them to spark the growth they hope for.","listText":"The outlook&nbsp;shows&nbsp;that even the senior management thinks they not gonna grow by a large margin because :1. Omnicron not as deadly so people's mentality not as afraid and hence don't really need to visit doctor for help2. People's behaviour&nbsp;has not&nbsp;really switched to tele health services muchTherefore, we might need to see some sort of behavioural change in people for them to spark the growth they hope for.","text":"The outlook shows that even the senior management thinks they not gonna grow by a large margin because :1. Omnicron not as deadly so people's mentality not as afraid and hence don't really need to visit doctor for help2. People's behaviour has not really switched to tele health services muchTherefore, we might need to see some sort of behavioural change in people for them to spark the growth they hope for.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030062252","repostId":2213957778,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9097724688,"gmtCreate":1645572290744,"gmtModify":1676534039890,"author":{"id":"3553658931361428","authorId":"3553658931361428","name":"yaozong7","avatar":"https://community-static.tradeup.com/news/0db82c58fe151c6056334e54bf8ceeee","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3553658931361428","idStr":"3553658931361428"},"htmlText":"Poor teladoc. Low can go lower indeed","listText":"Poor teladoc. Low can go lower indeed","text":"Poor teladoc. Low can go lower indeed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9097724688","repostId":2213957778,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9097729137,"gmtCreate":1645571487323,"gmtModify":1676534039672,"author":{"id":"3575693458669579","authorId":"3575693458669579","name":"Lavender00","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3575693458669579","idStr":"3575693458669579"},"htmlText":"Q4 EPS -0.07. Thought this is going to be profitable soon.&nbsp;next Q&nbsp;EPS highest estimated -0.50.&nbsp;[Speechless]&nbsp;","listText":"Q4 EPS -0.07. Thought this is going to be profitable soon.&nbsp;next Q&nbsp;EPS highest estimated -0.50.&nbsp;[Speechless]&nbsp;","text":"Q4 EPS -0.07. Thought this is going to be profitable soon. next Q EPS highest estimated -0.50. [Speechless]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9097729137","repostId":2213957778,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":9,"commentSize":3,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}